Rizatriptan Benzoate

Product NDC
0093-7471
11-digit product format
000937471
Labeler code
0093
Product ID
0093-7471_fe55c129-f82a-46c6-add0-e9f1d405eec6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Rizatriptan Benzoate
Dosage form
TABLET
Route
ORAL
Labeler
Teva Pharmaceuticals USA, Inc.
Application
ANDA077263
Marketing category
ANDA
Marketing start
2013-02-12
Substance
RIZATRIPTAN BENZOATE
Active strength
5 mg/1
Pharmacologic classes
Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Rizatriptan Benzoate
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
RIZATRIPTAN BENZOATE5 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiWR978S7QHH
Rxcui312840, 314209

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f2791553-0b76-42f4-8d49-af3eda072bfbProduct name120251117
707ffe6e-db52-42b0-9a65-a0c00213f04fProduct name120231006
8b537454-32b8-7e64-1395-258682782d07Product name520170424

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0093-7471-19Rizatriptan Benzoate1 in 1 BLISTER PACKTABLET18
0093-7471-43Rizatriptan Benzoate18 in 1 BOXTABLET188

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0093-7471-19EA - Each0093-7471e6fe05ba-b972-46a1-8d62-e489ed889fd812013-03-03
0093-7471-43EA - Each0093-7471e4144fec-8d7e-4eb6-ae23-c44cc25293d512013-03-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
RIZATRIPTAN BENZOATEACTIVE INGREDIENTWR978S7QHHRIZATRIPTAN BENZOATE TABLET [TEVA PHARMACEUTICALS USA INC]2
RIZATRIPTANACTIVE MOIETY51086HBW8GRIZATRIPTAN BENZOATE TABLET [TEVA PHARMACEUTICALS USA INC]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61URIZATRIPTAN BENZOATE TABLET [TEVA PHARMACEUTICALS USA INC]2
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XRIZATRIPTAN BENZOATE TABLET [TEVA PHARMACEUTICALS USA INC]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30RIZATRIPTAN BENZOATE TABLET [TEVA PHARMACEUTICALS USA INC]2
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2RIZATRIPTAN BENZOATE TABLET [TEVA PHARMACEUTICALS USA INC]2
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJRIZATRIPTAN BENZOATE TABLET [TEVA PHARMACEUTICALS USA INC]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0093-7471RIZATRIPTAN BENZOATE TABLET [TEVA PHARMACEUTICALS USA, INC.]8Current NDC, Legacy NDC, 2 package rows20241114_4ef60c83-ba48-4134-968b-13800ea9b7f2.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
314209rizatriptan benzoate 10 MG Oral TabletPSN4ef60c83-ba48-4134-968b-13800ea9b7f28
312840rizatriptan benzoate 5 MG Oral TabletPSN4ef60c83-ba48-4134-968b-13800ea9b7f28
314209rizatriptan 10 MG Oral TabletSCD4ef60c83-ba48-4134-968b-13800ea9b7f28
312840rizatriptan 5 MG Oral TabletSCD4ef60c83-ba48-4134-968b-13800ea9b7f28
314209rizatriptan 10 MG (as rizatriptan benzoate 14.53 MG) Oral TabletSY4ef60c83-ba48-4134-968b-13800ea9b7f28
312840rizatriptan 5 MG (as rizatriptan benzoate 7.265 MG) Oral TabletSY4ef60c83-ba48-4134-968b-13800ea9b7f28

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0093-7471-19000937471191 in 1 BLISTER PACKHistorical
0093-7471-430009374714318 BLISTER PACK in 1 BOX (0093-7471-43) / 1 TABLET in 1 BLISTER PACK (0093-7471-19) 18 blister pack2013-02-120000-00-00NoNoCurrent